Diabetes News and Research

Latest Diabetes News and Research

Advanced BioHealing commences efficacy trial of Dermagraft in the treatment of VLUs

Advanced BioHealing commences efficacy trial of Dermagraft in the treatment of VLUs

Alkermes commences phase 2 study of ALKS 33 in patients with alcohol dependence

Alkermes commences phase 2 study of ALKS 33 in patients with alcohol dependence

Recent developments at Burnham Institute for Medical Research

Recent developments at Burnham Institute for Medical Research

Global Alliance for Chronic Disease to fight against chronic non-communicable diseases

Global Alliance for Chronic Disease to fight against chronic non-communicable diseases

deCODE genetics files voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code

deCODE genetics files voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code

Play video games to prevent or improve obesity and lifestyle-related disease

Play video games to prevent or improve obesity and lifestyle-related disease

Program for childhood cancer survivors to quit smoking

Program for childhood cancer survivors to quit smoking

Roche receives EUA from FDA for its RealTime ready Influenza A/H1N1 Detection Set for the 2009 H1N1 virus

Roche receives EUA from FDA for its RealTime ready Influenza A/H1N1 Detection Set for the 2009 H1N1 virus

Nutrition is crucial to achieve the most desirable complexion

Nutrition is crucial to achieve the most desirable complexion

Antioxidant found in vegetables can protect cells from damage caused by infection and injury

Antioxidant found in vegetables can protect cells from damage caused by infection and injury

GSK-3alpha protein: A potent, positive regulator of cardiac hypertrophy

GSK-3alpha protein: A potent, positive regulator of cardiac hypertrophy

ECR Pharmaceuticals to commercialize and manufacture ZolpiMist in the U.S. and Canada

ECR Pharmaceuticals to commercialize and manufacture ZolpiMist in the U.S. and Canada

Update from Novo Nordisk regarding its share repurchase programme

Update from Novo Nordisk regarding its share repurchase programme

Addrenex Pharmaceuticals to be acquired by Sciele Pharma

Addrenex Pharmaceuticals to be acquired by Sciele Pharma

Interim data from Hollis-Eden Pharmaceuticals' Apoptone Phase I/II clinical trial presented

Interim data from Hollis-Eden Pharmaceuticals' Apoptone Phase I/II clinical trial presented

Lotus Pharmaceuticals reports $5.4 million net earnings for third-quarter 2009

Lotus Pharmaceuticals reports $5.4 million net earnings for third-quarter 2009

Color of skin impacts health, say researchers

Color of skin impacts health, say researchers

Alkermes' phase 3 trial of naltrexone XR-NTX meets primary endpoint

Alkermes' phase 3 trial of naltrexone XR-NTX meets primary endpoint

Mayo Clinic Health Letter provides treatment options for people with heart disorders

Mayo Clinic Health Letter provides treatment options for people with heart disorders

FDA issues a Complete Response Letter for Human Genome Sciences' raxibacumab BLA

FDA issues a Complete Response Letter for Human Genome Sciences' raxibacumab BLA

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.